Phase 1 2 trials
Phase 1
NCT04230330 Dec 2019 → Jun 2020 mature T-cell and NK-cell non-Hodgkin lymphoma National Cancer Centre, Singapore
Withdrawn
No outcome recorded
Phase 1
NCT01910428 Oct 2013 → Jan 2018 acute lymphoblastic leukemia , lymphoblastic lymphoma ERYtech Pharma
Terminated
No outcome recorded
Stop: Business
Phase 2 6 trials
Phase 2
NCT05827549 Apr 2024 → Dec 2032 expected acute lymphoblastic leukemia Ho Joon Im
Recruiting
No outcome recorded
Phase 2
NCT03599960 May 2019 → Feb 2023 CD4+/CD56+ hematodermic neoplasm Centre Hospitalier Universitaire de Besancon
Unknown
No outcome recorded
Phase 2
NCT02544425 Feb 2016 → Aug 2021 mature T-cell and NK-cell non-Hodgkin lymphoma Samsung Medical Center
Unknown
No outcome recorded
Phase 2
NCT00854425 Jun 2008 → Jan 2012 lymphoma Fudan University
Completed
No outcome recorded
Phase 2
NCT00186875 Nov 2003 → Aug 2016 acute lymphoblastic leukemia , lymphoblastic lymphoma St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 2
NCT00610883 May 1990 → Dec 2008 non-Hodgkin lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 3 3 trials
Phase 3
NCT03623087 Jul 2017 → Mar 2020 T-cell non-Hodgkin lymphoma , extranodal nasal NK/T cell lymphoma The University of Hong Kong
Unknown
No outcome recorded
Phase 3
NCT00137111 Jul 2000 → Nov 2010 acute lymphoblastic leukemia St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 3
NCT00187005 Jul 1998 → Jul 2002 acute lymphoblastic leukemia St. Jude Children's Research Hospital
Terminated
No outcome recorded
Phase 4 7 trials · 2 met primary
Phase 4
NCT03071822 Feb 2017 → Jul 2021 T-cell non-Hodgkin lymphoma The University of Hong Kong
Unknown
No outcome recorded
Phase 4
NCT01501149 Jan 2011 → Dec 2015 extranodal nasal NK/T cell lymphoma Mingzhi Zhang
Unknown
Met primary
Phase 4
NCT02894645 Oct 2008 → Oct 2018 childhood acute lymphoblastic leukemia National University Hospital, Singapore
Unknown
Met primary
Phase 4
NCT02036489 Jan 2008 → Dec 2019 acute lymphoblastic leukemia PETHEMA Foundation
Completed
No outcome recorded
Phase 4
NCT00526409 Jun 2005 → Oct 2014 acute lymphoblastic leukemia PETHEMA Foundation
Completed
No outcome recorded
Phase 4
NCT00526175 Jun 2001 → May 2015 acute lymphoblastic leukemia PETHEMA Foundation
Completed
No outcome recorded
Phase 4
NCT00526305 Jan 2000 → Apr 2005 acute lymphoblastic leukemia PETHEMA Foundation
Completed
No outcome recorded
Phase not applicable 3 trials
— NCT00161239 Feb 2005 → Oct 2007 T-cell non-Hodgkin lymphoma University of Medicine and Dentistry of New Jersey
Terminated
No outcome recorded
— NCT00187057 Sep 2002 → Aug 2006 ataxia telangiectasia St. Jude Children's Research Hospital
Completed
No outcome recorded
— NCT00187122 Mar 1993 → Jun 2004 lymphoblastic lymphoma St. Jude Children's Research Hospital
Completed
No outcome recorded
Comparator or background therapy 18 trials
Phase 1/2
NCT07585734 Background Apr 2025 → Apr 2026 T-cell acute lymphoblastic leukemia Institute of Hematology & Blood Diseases Hospital, China
Withdrawn
No outcome recorded
Phase 1/2
NCT03246750 Background Jan 2019 → Apr 2024 extranodal nasal NK/T cell lymphoma The Thai Lymphoma Study Group
Completed
No outcome recorded
Phase 1/2
NCT00098839 Background Feb 2005 → Apr 2011 childhood acute lymphoblastic leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT06099366 Background Mar 2024 → Dec 2033 expected childhood acute lymphoblastic leukemia Hee Young Ju
Recruiting
No outcome recorded
Phase 2
NCT04440267 Background Jul 2020 → Jun 2026 overdue acute leukemia of ambiguous lineage Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 2
NCT06336395 Background Mar 2020 → Mar 2030 expected B-cell acute lymphoblastic leukemia National University Hospital, Singapore
Recruiting
No outcome recorded
Phase 2
NCT03860844 Background Aug 2019 → Sep 2022 acute lymphoblastic leukemia , acute myeloid leukemia Sanofi
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT00873093 Background Mar 2009 → Sep 2014 B-cell adult acute lymphocytic leukemia , B-cell childhood acute lymphoblastic leukemia , T-cell adult acute lymphocytic leukemia , T-cell childhood acute lymphocytic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00195871 Background Feb 2004 → Jun 2014 lymphoblastic lymphoma Centre Henri Becquerel
Unknown
No outcome recorded
Phase 2
NCT00131053 Background Sep 2002 → May 2011 acute lymphoblastic leukemia Japan Adult Leukemia Study Group
Unknown
No outcome recorded
Phase 2
NCT00176462 Background Feb 2001 → Sep 2008 acute lymphoblastic leukemia Rutgers, The State University of New Jersey
Completed
No outcome recorded
Phase 2/3
NCT02451774 Comparator Jan 2015 → Dec 2019 childhood acute lymphoblastic leukemia Ramón Óscar González-Ramella, Ph.D
Unknown
No outcome recorded
Phase 2/3
NCT01518517 Comparator Dec 2009 → Sep 2014 acute lymphoblastic leukemia ERYtech Pharma
Completed
Met primary
Phase 3
NCT02665065 Comparator Jun 2016 → Jun 2022 overdue acute myeloid leukemia Actinium Pharmaceuticals
Active not recruiting
Met primary
Phase 3
NCT00131027 Background Sep 2002 → Mar 2011 acute lymphoblastic leukemia Japan Adult Leukemia Study Group
Unknown
No outcome recorded
Phase 3
NCT00136084 Background Aug 2002 → Jul 2008 acute myeloid leukemia St. Jude Children's Research Hospital
Completed
Missed primary
Phase 4
NCT01358253 Background Dec 2010 → Dec 2012 adult acute lymphoblastic leukemia Ruijin Hospital
Completed
No outcome recorded
— NCT03390387 Comparator Nov 2015 → Nov 2020 childhood acute lymphoblastic leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Unknown
No outcome recorded
Show 13 more trials